Retinoblastoma International is categorized under Commercial Medical Research in Los Angeles, CA and active since 1999.
Retinoblastoma International was established in 1999, and today employs 1 to 4, earning $50.000 to $99.999 per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Sheryl Turner at the company’s single location by writing to 4650 West Sunset Boulevard 88, Los Angeles, California CA 90027 or by phoning No number given. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Retinoblastoma International |
| Contact Person: | Sheryl Turner |
| Address: | 4650 West Sunset Boulevard 88, Los Angeles, California 90027 |
| Annual Revenue (USD): | $50.000 to $99.999 |
| Founded: | 1999 |
| Location Type: | Single Location |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Retinoblastoma International was started in 1999 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of $50.000 to $99.999 per annum.
Feel free to contact Sheryl Turner for inquiries that concern Retinoblastoma International by calling the company number No number given, as your correspondence is most welcome. Additionally, the physical location of the single location of Retinoblastoma International can be found at the coordinates as well as the street address 4650 West Sunset Boulevard 88 in Los Angeles, California 90027.
For its online presence, you may visit Retinoblastoma International’s website at and engage with its social media outlets through on Twitter and on Facebook.